FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and medicine. A compound (I) has an affinity to some subtypes of somatostatin receptors, and therefore can be used as a therapeutically active peptide in developing formulations of therapeutic agents for treating pathological conditions or diseases, which involve one or more somatostatin receptors. Besides, the compound (I) can be used as a peptide used as a carrier in prescription formulations.
EFFECT: what is presented is a new octapeptide compound of general formula (I): H-2-Nal1-cyclo(Cys2-Tyr3-AA4-Lys5-Val6-Cys7)-Thr8-NH2.
20 cl, 3 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW OCTAPEPTIDE COMPOUNDS AND THEIR THERAPEUTIC APPLICATION | 2011 |
|
RU2595525C2 |
| BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
| DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
| THROMBIN INHIBITORS AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS | 1995 |
|
RU2172741C2 |
| SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
| PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
| SUBSTITUTED PROLYLTYROSINES SHOWING PSYCHOTROPIC ACTIVITY | 1995 |
|
RU2091390C1 |
| PEPTIDE DERIVATIVES, THEIR STEREOISOMERS OR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING ANTITHROMBOSIS, ANTICOAGULATING OR ANTI-INFLAMMATORY ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF SUPPRESSION OF THROMBIN ACTIVITY, METHOD OF INHIBITION OF KININOGENASES ACTIVITY, USE OF COMPOUNDS AS PARENT SUBSTANCES FOR SYNTHESIS OF THROMBIN INHIBITOR | 1994 |
|
RU2142469C1 |
| METHOD OF OBTAINING BICYCLIC PEPTIDE COMPOUNDS | 2003 |
|
RU2330045C9 |
| AMINOISOQUINOLINE THROMBIN INHIBITOR WITH IMPROVED BIOAVAILABILITY | 2007 |
|
RU2437879C2 |
